Analyst sentiment shift puts Butterfly Network in focus

Butterfly Network (BFLY) is drawing fresh attention after its full year earnings estimates were raised and the stock received a Zacks Rank of #2 (Buy), which signals improving confidence among covering analysts.

The stock has been volatile, with a 90 day share price return of 44.19% and a 30 day share price return down 16.14%, while the 1 year total shareholder return of 76.68% points to momentum that has built over a longer stretch despite recent swings.

If Butterfly Network’s recent move has you thinking about where else AI in healthcare could go next, it is worth checking out 34 healthcare AI stocks

With the stock up strongly over the past year, trading at $4.47 and sitting below an average analyst price target of $5.69, you now have to ask if Butterfly Network is still mispriced or if the market already sees the next leg of growth.

Most Popular Narrative: 148.3% Overvalued

The most followed valuation narrative for Butterfly Network puts fair value at $1.80 per share, well below the last close of $4.47. This sets up a clear tension between narrative and market pricing.

In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.

This narrative, according to Gil263, leans heavily on long term revenue potential, improving margins and a future earnings multiple that assumes meaningful scale and stronger profitability.

Result: Fair Value of $1.80 (OVERVALUED)

However, this hinges on execution, and setbacks around the Midjourney agreement or weaker than expected adoption of Compass AI could quickly challenge that bullish outlook.

Next Steps

With sentiment clearly split between risks and rewards, now is the time to look at the facts yourself and decide what really matters. Start by weighing the 2 key rewards and 3 important warning signs

Looking for more investment ideas?

If Butterfly Network has sharpened your focus, do not stop here. The screener can help you quickly spot other stocks that might fit your approach.

• Zero in on potential bargains by scanning 48 high quality undervalued stocks that pair quality fundamentals with prices some investors may be overlooking.
• Prioritise resilience and address downside worries by reviewing 65 resilient stocks with low risk scores that score strongly on financial strength and risk metrics.
• Review the screener containing 21 high quality undiscovered gems before wider attention and pricing potentially catch up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.